With years of investment, pharmaceutical, regulatory, and deal structure experience, Intrinsic Capital Partners aims to build and scale industry-leading companies that address unmet needs across the supply chain. They have a strong network of operating partners and are dedicated to creating value for portfolio company owners while generating superior returns for their fund investors. The fund typically invests in startups that are 2-3 years old and have specific founders that they favor. They have made investments in companies like Hound Labs and Treez, and their preferred investment areas include cannabis and healthcare. In terms of funding rounds, they typically invest alongside 5-6 other participants and have been sponsored by WelCan Capital, Scott H. Cohen, Salveo Capital, and NFP Ventures. The fund has been most active in 2019 and typically completes less than 2 deals per year, with deal sizes ranging from $10-50 million.